Morningstar Investor users sign in here.

Company Profile

  • Business description

    Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company operates within a single operating segment the research and development of cancer indications, and operates primarily in one geographic area, being North America.

  • Contact

    9920 Pacific Heights Blvd
    Suite 150
    San Diego CA 92121
    USA

    T: +1 858 350-4364

    E: ir@delmarpharma.com

    https://www.kintara.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2024

    Employees

    2

Stocks News & Analysis

stocks

The secrets of Australia’s Berkshire Hathaway

Washington H. Soul Pattinson is an ASX top 50 stock with one of the best investment track records this country has seen. Yet, most Australians haven’t heard of it, and the company seems to prefer it that way.
stocks

Have some of the ASX 200's worst performers fallen too far?

These four stocks have had an awful twelve months. Morningstar's analysts weigh in on whether they offer good value yet. 
stocks

Private equity bid dramatically undervalues ASX listed share

We believe the bid is an attempt to capitalise on share price weakness. 

Markets

Index
Last price
Change
% Change
All Ordinaries 8,002.50 39.40 0.49%
CAC 40 7,805.79 58.91 -0.75%
DAX 40 18,499.36 131.50 -0.71%
Dow JONES (US) 38,712.21 35.21 -0.09%
FTSE 100 8,184.54 30.94 -0.38%
HKSE 18,112.63 174.79 0.97%
NASDAQ 17,608.44 264.89 1.53%
Nikkei 225 38,720.47 156.24 -0.40%
NZX 50 Index 11,872.64 130.76 1.11%
S&P 500 5,421.03 45.71 0.85%
S&P/ASX 200 7,749.70 34.20 0.44%
SSE Composite Index 3,028.92 8.55 -0.28%

Market Movers

Name
Last price
Change
% Change
Sigma Healthcare Ltd SIG 1.16 0.05 -3.73%
Peninsula Energy Ltd PEN 0.10 0.00 4.17%
South32 Ltd S32 3.64 0.00 0.00%
Pilbara Minerals Ltd PLS 3.32 0.09 -2.64%
Telstra Group Ltd TLS 3.53 0.01 0.28%
Core Lithium Ltd CXO 0.09 0.00 -1.05%
Red 5 Ltd RED 0.44 0.01 1.15%
Mirvac Group MGR 1.93 0.03 1.58%
TerraCom Ltd TER 0.22 0.01 -2.27%
Imugene Ltd IMU 0.06 0.00 1.75%